Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Malnutrition × maltodextrin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 3 Colonic Neoplasms 3 Prostatic Neoplasms 2 Polycystic Ovary Syndrome 2 Diarrhea 2 Vaso-Occlusive Crises 1 Seaweed Associated Changes in Healthy Subjects 1 Sarcopenia 1 Rectal Neoplasms 1 Proctitis 1 Neoplasms 1 Multiple Myeloma 1 Mucositis 1 Metabolic Syndrome 1 Malnutrition 1 Lymphoma 1 Liver Failure 1 Insulin Resistance 1 Hyperandrogenism 1 Head and Neck Neoplasms 1 Glucose Intolerance 1 Fibrosis 1 Colonic Polyps 1 Cholangiocarcinoma 1 Chemotherapy-related Diarrhea 1 Carcinoma, Hepatocellular 1 Anovulation 1 Anemia, Sickle Cell 1

Interventions

Nutritional Status 5 Nutrition Assessment 5 Enteral Nutrition 5 fish oil triglycerides 4 Standard of Care 4 Diet Therapy 4 Parenteral Nutrition 3 Nutrition Therapy 3 Dietary Supplements 3 Control Groups 3 alanylglutamine 2 Probiotics 2 Octreotide 2 Immunonutrition Diet 2 Exercise 2 Docosahexaenoic Acids 2 Docetaxel 2 Diet 2 Cisplatin 2 Chemotherapy, Adjuvant 2 Amino Acids 2 soybean oil, phospholipid emulsion 1 phosphatidyltransferase, Clostridium butyricum 1 maltodextrin 1 Vitamins 1 Radiotherapy 1 Radiation 1 Quality of Life 1 Psychology 1 Psychiatric Rehabilitation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03908255 2022-01-28

BCAA in HCC

Louisiana State University Health Sciences Center in New Orleans

Phase 2 Withdrawn

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Failure, Malnutrition

Data powered by HemOnc (CC BY 4.0) Colophon ⚡